A double-blind, placebo controlled, randomised, comparative, single-centre trial to assess the effects on the androgen metabolism and its effect on biochemical parameters, mood, fat, muscle and bone of continuous supplementation with an androgen in women using a monophasic contraception.

Trial Profile

A double-blind, placebo controlled, randomised, comparative, single-centre trial to assess the effects on the androgen metabolism and its effect on biochemical parameters, mood, fat, muscle and bone of continuous supplementation with an androgen in women using a monophasic contraception.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 May 2016

At a glance

  • Drugs Prasterone (Primary)
  • Indications Adrenal insufficiency
  • Focus Pharmacodynamics
  • Acronyms ARC-AMUSA
  • Sponsors Pantarhei Bioscience
  • Most Recent Events

    • 01 Jul 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 04 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top